Changes in peripheral blood T-cell balance after percutaneous tumor ablation

Purpose: To evaluate the changes in T-cell balance in peripheral blood following percutaneous tumor ablation. Material and methods: Patients underwent thermal ablation including radiofrequency (n = 9) and microwave ablation (n = 5), or cryoablation (n = 5). Target tumors were located in the lung (n ...

Full description

Saved in:
Bibliographic Details
Published inMinimally invasive therapy and allied technologies Vol. 26; no. 6; pp. 331 - 337
Main Authors Takaki, Haruyuki, Imai, Naoko, Thomas, Contessa T., Yamakado, Koichiro, Yarmohammadi, Hooman, Ziv, Etay, Srimathveeravalli, Govindarajan, Sofocleous, Constantinos T., Solomon, Stephen B., Erinjeri, Joseph P.
Format Journal Article
LanguageEnglish
Published England Taylor & Francis 02.11.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Purpose: To evaluate the changes in T-cell balance in peripheral blood following percutaneous tumor ablation. Material and methods: Patients underwent thermal ablation including radiofrequency (n = 9) and microwave ablation (n = 5), or cryoablation (n = 5). Target tumors were located in the lung (n = 7), soft tissue (n = 5), liver (n = 4), and bone (n = 3). Patient peripheral blood samples were collected before and within 14 days after ablation. Peripheral blood populations of cytotoxic T-cells (CTL), type-1 (T h 1) and type-2 helper T-cells (T h 2), and regulatory T-cells (T reg ) were measured using flow cytometry. Changes in CTL/T reg and T h 1/T h 2 ratios before and after ablation therapy were compared using paired t-tests. Results: Peripheral blood CTL population (27.5 ± 2.1% to 30.2 ± 2.5%, p < .03) and CTL/T reg ratios (18.8 ± 3.7% to 21.6 ± 3.6%, p < .05) increased significantly after ablation. Although a significant increase in CTL/T reg ratios was found after heat-based ablation (18.0 ± 4.4% to 21.6 ± 4.7%, p < .02), it remained unchanged after cryoablation (21.0 ± 7.0% to 21.5 ± 4.3%, p = .92). T h 1/T h 2 ratio (13.7 ± 3.0% to 17.2 ± 3.5%, p = .12) remained unchanged after ablation. Conclusion: Ablation therapy alters the T-cell balance by increasing the systemic CTL/T reg, ratio. Heat-based ablation might be a more effective approach than cryoablation to enhance systemic anti-tumor immunity.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1364-5706
1365-2931
1365-2931
DOI:10.1080/13645706.2017.1310737